Prognostic Value of P-Glycoprotein and Leukocyte Differentiation Antigens in Chronic Myeloid Leukemia

Leukemia and Lymphoma

Volumn 28, Issue 42130, 1998, Pages 469-482

  Stavrovskaya, Alla ^a,c   Turkina, Anna ^b   Sedyakhina, Natalia ^a   Stromskaya, Tatjana ^a   Zabottna, Tatjana ^a   Khoroshko, Nina ^b   Baryshnikov, Anatoly ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

^c Cancer Research Center   (Russian Federation)

Author keywords

CD 13; CD34; Chronic myeloid leukemia; multidrug resistance; P glycoprotein

Indexed keywords

CD34 ANTIGEN; DIFFERENTIATION ANTIGEN; GLYCOPROTEIN P; MICROSOMAL AMINOPEPTIDASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; BLAST CELL CRISIS; CHRONIC MYELOID LEUKEMIA; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; TERMINAL DISEASE; TREATMENT FAILURE;

ANTIGENS, CD; DRUG RESISTANCE, MULTIPLE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTES; P-GLYCOPROTEIN; PROGNOSIS;

EID: 0031898963     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199809058354     Document Type: Article

References (44)

1. Hill B. T. Drug resistance: An overview of the current sate of the art. Int. J. Oncol. 1996; 9: 197 – 203
2. Bradley G., Ling V. P-glycoprotein, multidrug resistance and tumor progression. Cancer and Metastasis Rev. 1994; 13: 223 – 233
3. Roninson I. B. Structure and evolution of P-glycoproteins. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, I. B. Roninson. Plenum Press, New York, 179 – 214
4. de Graaf D., Sharma R. C., Mechetner E., Shimke R. T., Roninson I. B. P-glycoprotein confers resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake. Proc. Natl. Acad. Sci USA 1996; 93: 1238 – 1242
5. Gottesman M. M., Willingham M. C., Thiebaut F., Pastan I. P-glycoprotein expression in normal human tissues. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells, I. B. Roninson. Plenum Press, New York 1991; 279 – 289
6. Chaudhary P. M., Roninson I. B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hemopoietic stem cells. Cell 1991; 66: 85 – 94
7. Drach D., Zhao S., Drach J., Mahadevia R., Cattringer C., Huber H., Andreeff M. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 1992; 80: 2729 – 2734
8. Drach J., Zhao S., Drach D., Korbing M., Engel H., Andreef M. Expression of MDR1 by normal bone marrow cells and its implication for leukemic hematopoiesis. Lymphoma 1995; 16: 419 – 424
9. List A. F. Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 1996; 10: 937 – 942
10. Takeshita A., Shinjo K., Ohnishi K., Ohno R. Expression of multidrug resistance P-glycoprotein in myeloid progenitor cells of different phenotype: comparison between normal bone marrow cells and leukemia cells. Br. J. Haematol. 1996; 93: 18 – 21
11. Chaudhary P. M., Mechetner E. B., Roninson J. B. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 1993; 80: 2735 – 2739
12. Chong A. S.-F., Markham P. N., Gebel H. M., Bines S. D., Coon J. S. Diverse multidrug-resistance-modification agents inhibit activity of natural killer cells. Cancer Immunol. Immunother. 1993; 36: 133 – 139
13. Campos L., Goyotat D., Archimbaud E., Pascale C. -O., Tsuruo T., Troncy J., Treille D., Fiere D. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia. Blood 1992; 79: 473 – 476
14. Nooter K., Sonneveld P. Multidrug resistance (MDR) genes in haematological malignancies. Cytotechnology 1993; 12: 213 – 230
15. Goldstein L. J., Galski H., Fojo A., Willingham M., Lai S. -L., Gazdar A., Pirker R., Green A., Cirst W., Brodeur G. M., Grant C., Lieber M., Cossman J., Gottesman M. M., Pastan I. Expression of multidrug resistance gene in human cancers. J. Natl. Cancer Inst 1989; 81: 116 – 124
16. Sato H., Gottesman M. M., Goldstein L. J., Pastan I., Block A. M., Sandberg A. A., Preisler H. D. Expression of multidrug resistance gene in myeloid leukemias. Leukemia Res. 1990; 14: 11 – 22
17. Nussler V., Pelka-Fleischer R., Zwerzina H., Neri C., Beckett B., Gullis E., Gieseler F., Bock S., Bartl R., Petrides P. E. Clinical importance of P-glycoprotein-related resistance in leukemia and myelodisplastic syndromes-first experience with their reversal. Ann. Hematoi 1994; 69: 25 – 29
18. Herweijer H., Sonneveld P., Baas F., Nooter K. Expresion of mdrl and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J. Natl. Cancer Inst. 1990; 82: 1133 – 1140
19. Weide R., Dowding C., Paulsen W., Goldman J. The role of MDR- 1/P-170 mechanism in development of multidrug resistance in chronic myeloid leukemia. Leukemia 1990; 4: 695 – 699
20. Michelutti A., Michieli M., Damiani D., Melli C., Geromin A., Russo D., Fanin R., Baccarani M. Overexpression of MDR-related P-170 glycoprotein in chronic myeloid leukemia. Haematologica 1994; 79: 200 – 204
21. Turkina A. G., Frolova E. A., Folomeshkina S. V., Sediakhina N. P., Sokolova M. A., Khoroshko N. D., Baryshnikov A. Ju., Stavrovskaya A. A. The clinical significance of the expression of the multiple-drug resistance protein, P-glycoprotein, in chronic myeloleukemia. Terapevtichesky Arhiv 1995; 67: 17 – 21, (in Russian)
22. Turkina A. G., Baryshnikov A. Ju., Sedyakhina N. P., Folomeshkina S. V., Sokolova M. A., Khoroshko N. D., Stavrovskaya A. A. Studies of P-glycoprotein in chronic myelogeneous leukemia patients: expression, activity and correlations with CD34 antigen. Br. J. Haematol. 1996; 92: 88 – 96
23. Kemnitz J., Fraud M., Dominism M., Cohnert T. R., Uyusal A., Georgii A. Detection of cells with multidrug-resistance phenotype in myeloproliferative disorders before therapy. Haematologic Pathology 1989; 3: 73 – 78
24. Frolova E. A., Baryshnikov A. Yu., Moiseenkova I. N., Tupitsin N. N., Turkina A. G. Heterogeneity in immunological types of chronic myeloid blast crisis. Haematologia i Transfusiologia 1992; 5: 6 – 11, (in Russian)
25. Baryshnikov A. Ju., Turkina A. G., Michailova I. N., Sedyakhina N. P., Shishkin Ju. V., Korolyova A. M., Palkina T. N., Ivanov P. K., Frolova E. A., Mokeyeva R. A., Khoroshko N. D. Gene Technology. Stem Cell and Leukemia Research, A. R. Zander, W. Ostertag, B. V. Afanasiev, F. Grosveld. NATO ASI Series, Series H: Cell biology, Springer-Verlag, Berlin, Heidelberg 1996; vol. 94: 475 – 784
26. Bates S. E., Mikley L. A., Chen Y-N., Richert N., Rudick J., Biedler J. L., Fojo A. T. Expression of a drug resistance gene in human neuroblastoma cell lines: Modulation by retinoic acid-induced differentiation. Mol. Cell. Biol 1989; 9: 4337 – 4344
27. Marie J. P., Faussat-Suberville A. M., Zhou D., Zittoun R. Daunorubicin uptake by leukemic cells: correlation with treatment outcome and mdrl expression. Leukemia 1993; 1: 825 – 831
28. Ross D. D., Woolen P. J., Sridhara R., Ordonez J. V., Lee E. J., Schitter C. A. Enhancement of daunorubicin accumulation, retention and cytotoxity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia. Blood 1993; 82: 1288 – 1299
29. Neyfakh A. A. Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp. Cell Res. 1988; 174: 168 – 176
30. Tapiero H., Munck J-N., Fourcade A., Lampidis T. J. Cross-resistance to rhodamine 123 and adriamycin-and daunorubicin-resistant Friend leukemia cell variants. Cancer Res. 1984; 185: 496 – 505
31. Egudina S. V., Stromskaya T. P., Frolova E. A., Stavrovskaya A. A. Early steps of the P-glycoprotein expression in cell cultures studied with vital fluorochrome. FEBS Letters 1993; 329: 63 – 66
32. Neyfakh A. A., Serpinskaya A. S., Chervonsky A. V., Apasov S. G., Kazarov A. R. Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection. Exp. Cell Res. 1989; 185: 496 – 505
33. Feller N., Kuiper C. M., Lankelma J., Rudhal J. K., Scheper R. J., Pinedo H. M., Broxterman H. J. Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. Br. J. Cancer 1995; 72: 543 – 549
34. Twentyman P. R., Rhodes T., Rayner S. A comparison of Rhodamine 123 accumulation and efflux in the cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. Eur J. Cancer 1994; 9: 1360 – 1369
35. Hollap Z., Homoloya L., Davis C. M., Sarkadi B. Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochem. Biophys. Acta 1994; 1191: 384 – 388
36. Lee E. J., Yang J., Leavitt R. D., Testa J. R., Civin C. K., Forrest A., Schiffer C. A. The significance of CD34 and TdT determination in patients with de novo acute myeloid leukemia. Leukemia 1992; 16: 1203 – 1209
37. Cacciola E., Gugliemo P., Cacciola E., Stagno F., Cacciola R. R., Impera S. CD34 expression in adult acute lymphoblastic leukemia. Leukemia & Lymphoma. 1995; 18: 31 – 37
38. List A. F., Spier C. M., Cline A., Doll D. C., Garewal H., Morgan R., Sandberg A. A. Expression of multidrug resistance gene product (P-glycoprotein) in myelodisplasia is associated with a stem cell phenotype. Br. J. Haemat. 1991; 78: 28 – 34
39. Myachi H., Takemura Y., Yonekura S., Komatsuda M., Ngao T., Arimori S., Ando Y. MDRI (multidrug resistance) gene expression in adult acute leukemia: correlations with blast phenotype. Int. J. Hematol. 1993; 57: 31 – 37
40. Kuwazuru Y., Yoshimura A., Hanada S., Ichikawa M., Saito T., Uozumi K., Utsunomiya A., Arima T. Expression of multidrug transporter, P-glycoprotein, in chronic myelogeneous leukemia cells in blast crisis. Br. J. Haemat. 1990; 74: 24 – 29
41. Gekeler V., Beck J., Noller A., Willisch A., Frese G., Neumann M., Handgretinger R., Ehninger G., Probst H., Niethammer D. Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias. Ann. Hematol. 1994; 69: 19 – 24
42. Stuif I., Sominskaya A., Bykova T., Zaritskey A. MDR1 gene expression in chronic myelogeneous leukemia: Prognostic marker of the disease. Gene Technology. Stem Cell and Leukemia Research, A. R. Zander, W. Ostertag, B. V. Afanasiev, F. Grosveld. NATO ASI Series, Series H: Cell biology, Springer-Verlag, Berlin, Heidelberg 1996; vol. 94: 175 – 179
43. Khoroshko N. D. Prognostic factors in chronic myloid leukemia. Terapevtichesky Archiv 1993; 7: 23 – 28, (in Russian)
44. Mechetner E. B., Roninson I. B. Efficient inhibition of P-glycoprotein -mediated multidrug resistance with a monoclonal antibody. Proc. Natl. Acad. Sci. USA 1992; 89: 5824 – 5828